Rising incidence of neurological disorders, rapid progress in drug discovery and development, and increasing discovery of new potential drug targets are key factors driving market growth
Market Size – USD 3.20 Billion in 2020, Market Growth – at a CAGR of 10.4%, Market Trends – Rising use of customized antibodies in precision medicine
The global neuroscience antibodies and assays market size is expected to reach USD 7.06 Billion by 2028 at a CAGR of 10.4%, according to the latest report by Reports and Data. Increasing prevalence of neurological disorders, rapid advancements in neurological research, and growing support by government and healthcare organizations to accelerate drug discovery and development for neurological disorders are key factors expected to drive market revenue growth over the forecast period. Increasing research and development in biopharmaceutical sector and rising demand for high-quality neuroscience antibodies to study novel and potential drug targets are also expected to drive market growth going ahead.
Neuroscience is a multidisciplinary field of science focused on studying the structure and function of nervous system. It comprises an integrated analysis of multiple cell types, tissues, and organs using different techniques. Recent advancements in neuroscience research has resulted in increased reliance on antibodies and immunodetection to understand the pathways and targets of neurological diseases. Antibodies, peptides, and proteins have expanded the scope of different areas of neuroscience research. Antibody-based approaches are critical tools in cellular and molecular neuroscience and has increased the knowledge about the abundance, distribution, function, and structure of proteins in the brain. Antibody-based methods are widely used in localization, isolation, and characterization of target proteins that form a fundamental base of neuroscience research. Antibodies targeting specific neurological disorders such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and other neurological diseases are widely available, and this is expected to further boost neuroscience research activities and contribute to market growth going ahead.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4060
The report provides a panoramic view of the market and insights that will help formulate better business decisions. In addition to that, the study helps well-established companies and players gain a deeper understanding of the market and make informed decisions. The report also discusses in detail about the key factors influencing the market growth.
Key companies operating in the market include:
Thermo Fisher Scientific, Inc., Abcam, Bio-Rad, Merck KGaA, BioLegend, Cell Signaling Technology, F. Hoffmann-La Roche, GenScript, Rockland Immunochemicals, Santa Cruz Biotechnology, Siemens, and Tecan.
The report covers an extensive analysis of the key market players in the market along with their business overview, expansion plans, and strategies. The report also focuses on recent strategic alliances in the market including mergers and acquisitions, joint ventures, partnerships, agreements, corporate and government deals, product launches, and brand promotions, among others.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/4060
The report aims to provide a better understanding of the market dynamics and the workings of the industry on a global level. To gain a deeper understanding of the industry, the global Neuroscience Antibodies and Assays market is further segmented on the basis of key geographical regions such as North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. The report also offers a country-wise analysis to provide crucial insights into market size, market growth, market revenue growth, and economic growth in each region.
The regional analysis covers:
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
To know more about the report @ https://www.reportsanddata.com/report-detail/neuroscience-antibodies-and-assays-market
On basis of product types and application offered by the Neuroscience Antibodies and Assays industry, the market is segmented into:
Product Outlook (Revenue, USD Billion; 2018-2028)
- Primary Antibodies
- Secondary Antibodies
- Assay Kits
- Microplate Readers
- Immunoassay Analyzers
- Other Instruments
Technology Outlook (Revenue, USD Billion; 2018-2028)
- Western Blotting
- Others Immunoassays Technologies
- Molecular Diagnostics
- Clinical Chemistry
- Other Technologies
Application Outlook (Revenue, USD Billion; 2018-2028)
- In Vitro Diagnostics
- Drug Discovery and Development
End-use Industry Outlook (Revenue, USD Billion; 2018-2028)
- Pharmaceutical and Biopharmaceutical Companies
- Academic and Research Institutes
- Hospital and Diagnostic Centers
Benefits of Neuroscience Antibodies and Assays Market Report:
- Panoramic overview of the opportunities and risks in the Neuroscience Antibodies and Assays sector
- Study of recent innovations and developments in the industry
- Comprehensive study of the growth pattern of the Neuroscience Antibodies and Assays industry
- In-depth assessment of the competitive landscape of the key players of the Neuroscience Antibodies and Assays industry
- Analysis of the Neuroscience Antibodies and Assays market drivers, constraints, and opportunities
- Assessment of technological developments and latest trends of the industry
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/4060
Thank you for reading our report. For customization or further inquiry, please get in touch with us. Our team will ensure the report is tailored according to your requirements.
Browse More Reports: